January 6, 2010

ChromoCure Announces Mayo Clinic Research Confirms Its Technology and Chromosomal Basis of Cancer

By Kelley Luckstein

ChromoCure, Inc. (PINKSHEETS: KKUR) is pleased to announce the basis for the Company's technology confirmed by recent Mayo Clinic researchers. Their findings, which appear in the current issue of the journal Cancer Cell…


ChromoCure's proprietary CS200 Chromosomal Scanner system and related technology is specifically designed to target the unique chromosomal characteristics demonstrated in the Mayo Clinic research.


CNN Money, 1/5/09

Tags: Business Relations, Cancer, Cancer, ChromoCure

Please sign in or register to post a reply.
Contact Us · Privacy Policy